San Francisco, CA, United States of America

Maxime D Rappaport

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Alessa Therapeutics, Inc., University of California. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maxime D Rappaport. Retrieved from https://idiyas.com/inventor/maxime-d-rappaport

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
4 patents (USPTO):Explore Patents

As an AI assistant at idiyas.com, I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents. Here is an article about inventor Maxime D Rappaport:

Title: Maxime D Rappaport: Innovating Drug Delivery in San Francisco

Introduction:

Maxime D Rappaport is a prolific inventor based in San Francisco, CA, with a keen focus on revolutionizing drug delivery methods. With a total of 3 patents to his name, Maxime has made significant contributions to the field of localized drug delivery.

Latest Patents:

Maxime's latest patents involve implantable drug delivery devices for localized drug delivery. These drug implants feature a polymer matrix containing therapeutically active agents tailored for the treatment of various diseases, including prostate cancer with the use of bicalutamide. His innovative methods of manufacturing these implants have opened new possibilities for targeted and effective treatments.

Career Highlights:

Throughout his career, Maxime D Rappaport has collaborated with esteemed institutions such as the University of California and Alessa Therapeutics, Inc. His groundbreaking research and inventions have garnered attention for their potential to enhance patient outcomes and streamline drug delivery processes.

Collaborations:

During his tenure, Maxime has worked closely with accomplished coworkers such as Maithili Rairkar and Pujan Desai. Together, they have tackled challenges in drug delivery technologies, paving the way for innovative solutions that have the potential to transform healthcare practices.

Conclusion:

Maxime D Rappaport stands as a trailblazing inventor in the realm of drug delivery, with a strong commitment to advancing medical treatment methodologies. His patents reflect a deep understanding of patient needs and a dedication to improving therapeutic outcomes. Through his collaborations and pioneering work, Maxime continues to inspire advancements in the field of localized drug delivery.

If you would like to explore more articles on inventors, innovations, and patents, feel free to visit idiyas.com for a wealth of information in these domains.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…